De­sign Ther­a­peu­tics hints at ‘strate­gic re­align­ment,’ re­places CEO; Karyopharm co-founder leads AT­P's Nereid

De­sign Ther­a­peu­tics chair­man Pratik Shah has suc­ceed­ed João Sif­fert as CEO while teas­ing a “strate­gic re­align­ment” that won’t be re­vealed un­til ear­ly 2024, …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.